Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Dec. 1, 2020, 5:02 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, outperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP jumped 18.85% to $1.45 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.28% to 12,355.11 and the Dow Jones Industrial Average DJIA rising 0.63% to 29,823.92. Corbus Pharmaceuticals Holdings Inc. closed $8.33 short of its 52-week high ($9.78), which the company achieved on August 31st.

The stock outperformed some of its competitors Tuesday, as Fate Therapeutics Inc. FATE rose 3.00% to $60.22, Vanda Pharmaceuticals Inc. VNDA rose 1.06% to $12.34, and Viking Therapeutics Inc. VKTX fell 2.64% to $6.26. Trading volume (25.9 M) eclipsed its 50-day average volume of 4.3 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.